More than 100 countries run organized programs to deworm their populations, with most concentrated across sub-Saharan Africa, South and Southeast Asia, Latin America, and the Pacific Islands. These are not fringe efforts: the World Health Organization coordinates a global strategy built around preventive chemotherapy, in which entire at-risk groups receive antiparasitic tablets, usually albendazole or mebendazole, on a fixed schedule regardless of whether each individual has been tested for infection. The scale is enormous, yet coverage remains uneven, and the scientific debate over whether mass deworming delivers lasting benefits is far from settled.
Why So Many Countries Deworm
Soil-transmitted helminths, the intestinal worms targeted by most deworming campaigns, thrive wherever warm temperatures, moist soil, and inadequate sanitation overlap. The main culprits are roundworm, whipworm, and hookworm. Together, they infect well over a billion people worldwide. Because these parasites spread through contaminated soil rather than person-to-person contact, the geography of infection maps neatly onto poverty: communities without reliable latrines, clean water, and paved surfaces carry the heaviest burden.
The goal of national control programs is to reduce the share of moderate and heavy infections in vulnerable groups, primarily preschool and school-age children, pregnant women, and certain adult workers in high-risk settings. Programs rely on preventive chemotherapy with albendazole or mebendazole, drugs that are cheap, single-dose, and donated in bulk by pharmaceutical companies.1PubMed Central. Sustained preventive chemotherapy for soil-transmitted helminthiases leads to reduction in prevalence and anthelminthic tablets required The simplicity of this approach is its greatest selling point: you don’t need a laboratory diagnosis, a trained clinician, or even a clinic. A teacher can hand a child a tablet during a school assembly.
Where Deworming Happens
A cross-sectional analysis covering roughly 820,000 children across 50 low- and middle-income countries in Africa, the Americas, Asia, and parts of Europe found that average deworming coverage among preschool children was about 33%.2PubMed Central. State of deworming coverage and equity in low-income and middle-income countries using household health surveys: a spatiotemporal cross-sectional study That figure masks wide variation: some countries reach the majority of their at-risk children, while others barely get started.
Sub-Saharan Africa carries the largest deworming burden. Countries like Kenya, Ethiopia, Nigeria, Tanzania, Uganda, and Malawi run annual or biannual mass drug administration rounds, often tied to the school calendar. Kenya’s coastal counties, where hookworm prevalence has historically been high, have piloted community-wide treatment reaching preschool-age children who would otherwise be missed by school-based programs.3PubMed Central. Lessons from implementing mass drug administration for soil transmitted helminths among pre-school aged children during school based deworming program at the Kenyan coast
India operates the world’s largest deworming program. Since 2015, the country has designated a National Deworming Day, during which schoolteachers distribute albendazole tablets to children. A study of over 400 teachers across 221 schools in Tamil Nadu found that while most had a basic grasp of the program, only about a third had adequate knowledge of the specifics: which worm species the drug targets, correct age eligibility, and possible side effects.4PubMed Central. School-based deworming programmes: Knowledge and perceptions regarding soil-transmitted helminth infections among schoolteachers in Tamil Nadu, India Training gaps like these matter because teachers are the front line of delivery in school-based programs.
Vietnam has tested whether extending deworming to entire communities, rather than only schoolchildren, does a better job of cutting transmission. A cluster-randomized trial there found that while community-wide and school-based approaches reduced hookworm prevalence by similar amounts, the community approach achieved a far greater reduction in the intensity of infection, particularly for moderate-to-heavy cases.5PubMed Central. Community-wide versus school-based targeted deworming for soil-transmitted helminth control in school-aged children in Vietnam: the CoDe-STH cluster-randomised controlled trial Adults who harbor worms but never receive treatment can reinfect children in the household, so limiting programs to schools may leave a reservoir of parasites intact.
In Latin America, Brazil, Honduras, and Haiti are among the countries with active programs. Turkey ran a school-based deworming effort in its southeastern provinces, where hookworm remained a concern into the 2000s. A community evaluation of that program uncovered an unexpected obstacle: some parents believed that the externally funded treatment was an experiment on their children, and others worried that mebendazole could cause sexual sterility.6The American Journal of Tropical Medicine and Hygiene. Community Perception of School-Based Deworming Program in Sanliurfa, Turkey These suspicions, rooted in distrust of outside funders, illustrate a recurring challenge for deworming campaigns everywhere.
Pacific Island nations have focused heavily on lymphatic filariasis elimination alongside soil-transmitted helminth control. Small countries like Niue and Tonga have reached the WHO threshold for elimination of lymphatic filariasis as a public health problem and now conduct post-validation surveillance to confirm that transmission has not bounced back.7PubMed Central. Integrated surveillance for lymphatic filariasis and other infectious diseases with a nationwide non-communicable disease STEPwise survey in the small Pacific Island Nation of Niue, 20258PubMed. Utility of antifilarial antibodies for post-validation surveillance of lymphatic filariasis in Tonga
The Diseases Beyond Intestinal Worms
When people hear “deworming,” they usually picture intestinal roundworm or hookworm. But human deworming programs target at least three distinct groups of parasites, each requiring different drugs and different delivery strategies.
Schistosomiasis, caused by blood flukes acquired through contact with contaminated freshwater, is a massive problem across much of Africa, parts of Southeast Asia, and pockets of South America. The backbone of control is mass drug administration using praziquantel, a different drug from the benzimidazoles used for soil-transmitted worms.9PubMed Central. Early lessons from schistosomiasis mass drug administration programs Countries like Uganda, Mozambique, and Tanzania distribute praziquantel through school-based campaigns in endemic districts.
Lymphatic filariasis, the mosquito-transmitted disease that can lead to severe limb swelling, is targeted by a different drug combination. In 2017, the WHO endorsed a triple-drug therapy combining ivermectin, diethylcarbamazine, and albendazole for settings where rapid elimination was the goal.10PubMed Central. Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned A clinical trial of this regimen found that it cleared microfilariae, the larval parasites circulating in the blood, in about 96% of participants, with that clearance sustained at three years.11PubMed Central. A Trial of a Triple-Drug Treatment for Lymphatic Filariasis India, which carries a huge share of the global lymphatic filariasis burden, has been scaling up this approach.
Kenya has mapped out a path to elimination of lymphatic filariasis by 2030, using a combination of mass drug administration and mosquito vector surveillance. The strategy includes molecular monitoring of mosquitoes to detect parasite DNA as an early warning system for renewed transmission.12International Journal of Infectious Diseases. Lymphatic filariasis elimination in Kenya: Tracing the journey from 2002-2024 and pathways to achieving 2030 target
The United States Used to Deworm Too
One fact that surprises many readers: the American South was once a major deworming zone. In the early 1900s, hookworm disease was widespread across eleven southern states, contributing to chronic fatigue, anemia, and stunted growth in rural communities. The Rockefeller Sanitary Commission, launched in 1909 with funding from John D. Rockefeller, surveyed infection rates and found that about 40% of the school-age population was infected.13PubMed Central. Extending public health: the Rockefeller Sanitary Commission and hookworm in the American South The commission then sponsored treatment campaigns across the region, and follow-up surveys showed that the effort substantially reduced hookworm almost immediately.14PubMed Central. Disease and Development: Evidence from Hookworm Eradication in the American South
What eliminated hookworm from the American South was not just drugs. It was the combination of treatment with massive investments in sanitation infrastructure: latrines, sewer systems, shoes, and paved roads. That combination is exactly what today’s endemic countries are struggling to replicate on a larger scale and with fewer resources.
Does Mass Deworming Actually Work Long-Term
This is where the science gets contentious. A landmark study tracking Kenyan children who received two to three extra years of school-based deworming found that, twenty years later, those individuals had about 14% higher consumption expenditures and 13% higher hourly earnings than controls. They were also about 9% more likely to live in urban areas and had shifted toward nonagricultural work. The estimated annualized social return on investment was 37%, a striking figure given how cheap deworming tablets are.15PubMed Central. Twenty-year economic impacts of deworming
A separate analysis of the same Kenyan program exploited a spillover effect: younger children who were not directly treated but lived in communities where school-based deworming occurred also benefited. About a decade later, children who had been under one year old during the campaign showed cognitive gains comparable to roughly half a year to nearly a year of additional schooling.16American Economic Journal: Applied Economics. Exploiting Externalities to Estimate the Long-Term Effects of Early Childhood Deworming
But these results have not gone unchallenged. A study following preschool-age children dewormed in Uganda found no statistically significant gains in numeracy or literacy seven to twelve years later, though the study acknowledged it lacked the statistical power to rule out meaningful effects in either direction.17PubMed Central. The long run impact of early childhood deworming on numeracy and literacy: Evidence from Uganda And a systematic review with individual participant data analysis reinforced the case against mass deworming at a population level, finding little effect on nutritional status or cognition.18PubMed Central. Mass deworming for improving health and cognition of children in endemic helminth areas: A systematic review and individual participant data network meta-analysis
The disagreement partly comes down to what you measure and when. Short-term nutritional markers like height and weight may not budge after deworming, while economic outcomes measured decades later may reflect cascading effects from reduced absenteeism and better childhood health. The setting also matters: deworming is more likely to produce visible gains in communities where infection intensity is high. Treating children who carry light infections in areas with moderate prevalence may not move the needle much.
Why Drugs Alone Are Not Enough
A recurring frustration in deworming programs is reinfection. You can treat an entire community and clear most of the worms, but if people are still walking barefoot on contaminated soil and drinking untreated water, new infections begin within months. A study among the Karen hill tribe in northern Thailand demonstrated this directly: mass drug administration alone failed to control intestinal parasites because behavioral and socioeconomic factors drove rapid reinfection. Adding structured education around water, sanitation, and hygiene (commonly called WASH) significantly reduced reinfection rates.19PubMed Central. The impact of an integrated intervention program combining drug therapy with water, sanitation, and hygiene (WASH) education on reinfection with intestinal parasitic infections among the Karen hill tribe in northern Thailand
A scoping review of WASH interventions in the context of soil-transmitted helminth control echoed this conclusion: the limitations of mass drug administration on its own underscore the need for complementary strategies.20PubMed Central. Impact and cost-effectiveness of water, sanitation, hygiene, and health education interventions in the control and elimination of soil-transmitted helminthiasis: A scoping review This is precisely the lesson the American South learned a century ago, and it remains the uncomfortable truth for modern programs: tablets treat the patient, but they don’t fix the environment that makes the patient sick.
Can Deworming Actually Break Transmission
Most current programs aim to control worm-related disease, not to wipe out the parasites entirely. But a large multicountry trial called DeWorm3, conducted in Benin, India, and Malawi, tested whether community-wide mass drug administration given frequently enough could interrupt transmission altogether. Two years after all deworming stopped, hookworm prevalence in the community-wide treatment groups remained roughly 60% lower than in the school-only groups across all three countries. However, true interruption of transmission, meaning zero ongoing spread, was achieved in only a fraction of the clusters studied, and even then mostly in Benin.21PubMed. Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi The results suggest that while aggressive community deworming can suppress transmission dramatically, complete elimination of hookworm is an elusive target, especially in high-burden settings.
Drug Resistance on the Horizon
The worming drugs used in livestock have already generated widespread resistance in animal parasites. Whether the same is happening in human helminths is a growing concern. A modeling study found that if resistance to benzimidazoles, the drug class that includes albendazole and mebendazole, has been developing over the past decade of mass treatment, existing monitoring may not have caught it. Standard efficacy surveys can sometimes show a low egg-reduction rate even in settings where no resistance exists, making it hard to distinguish real resistance from statistical noise. The researchers warned that strategies to monitor and mitigate benzimidazole resistance need to be developed and implemented urgently.22PubMed Central. Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy
This is particularly worrying because global deworming depends on a very narrow drug pipeline. Albendazole and mebendazole have been the workhorses for decades, and the drug donation programs that supply them at no cost to recipient countries, while successful in achieving wide coverage, have not encouraged the development of sustainable domestic procurement or alternative medicines.23PubMed Central. Implications of global health funding patterns for implementation of a novel soil-transmitted helminth and lymphatic filariasis medicine: Ivermectin/albendazole fixed-dose combination If resistance does emerge at scale, the fallback options are thin.
Deworming Pregnant Women
WHO recommends that pregnant women in endemic areas receive deworming treatment, but only after the first trimester. Programs have to find ways to screen for early pregnancy before distributing tablets, which adds a practical barrier in community-based campaigns where women may not know they are pregnant or may not disclose it.24PLOS Neglected Tropical Diseases. Ruling out early trimester pregnancy when implementing community-based deworming programs
A randomized controlled trial in Uganda found that deworming during pregnancy with albendazole did not improve maternal anemia overall or affect birth weight. There was, however, a suggestion of benefit for women who had moderate to heavy hookworm infections, a subgroup where the parasite’s blood-draining effect is most clinically relevant. Treatment showed no effect on perinatal mortality or congenital anomalies, which is at least reassuring on the safety front.25PubMed Central. Effects of Deworming during Pregnancy on Maternal and Perinatenal Outcomes in Entebbe, Uganda: A Randomized Controlled Trial
The Role of Animals and Shared Environments
Human deworming programs typically treat the problem as if humans are the only relevant hosts, but for some parasites the picture is more tangled. A study in coastal Cartagena, Colombia, found that households where dogs were not regularly dewormed had nearly four times the odds of human parasitic infections compared to households where dogs received antiparasitic treatment.26PubMed Central. One Health assessment of zoonotic intestinal parasites in humans, dogs, and soil of coastal Cartagena, Colombia The implication is that for zoonotic parasites, those that cycle between animals and humans, treating only one host species may not be enough to break the cycle. A “One Health” approach that addresses animal reservoirs alongside human treatment could improve outcomes, but it adds complexity and cost to programs that are already stretched thin.
What Deworming Does to the Gut Beyond Killing Worms
Albendazole doesn’t just kill helminths. It also appears to shift the composition of gut bacteria. Research in western Kenya found that after treatment cleared soil-transmitted helminths, there were significant changes in the gut microbiome: one group of bacteria (Clostridiales) increased while another (Enterobacteriales) decreased. Perhaps more unexpectedly, bacterial diversity dropped even among people who were uninfected before treatment, suggesting that albendazole has direct antimicrobial effects beyond its intended antiparasitic action.27PubMed Central. The Impact of Anthelmintic Treatment on Human Gut Microbiota Based on Cross-Sectional and Pre- and Postdeworming Comparisons in Western Kenya What this means clinically is still unclear, but it’s a reminder that mass drug administration is never a perfectly surgical intervention. There are off-target effects, and as programs scale up, understanding those effects becomes more relevant.
Better Diagnostics for a Post-Treatment World
Traditional diagnosis of soil-transmitted helminths relies on microscopy: a technician looks at a stool sample under a microscope and counts eggs. The method is cheap but insensitive, especially after treatment has reduced worm burdens to low levels. Molecular diagnostics like quantitative PCR can detect parasite DNA at much lower thresholds, which matters for programs that need to distinguish between communities where infection is under control and those where more treatment is needed.28PubMed Central. Multi-parallel qPCR provides increased sensitivity and diagnostic breadth for gastrointestinal parasites of humans: field-based inferences on the impact of mass deworming As countries move from a control phase toward potential elimination, the stakes of accurate measurement go up. A microscopy-based survey that declares a district worm-free may simply be missing low-level infections that molecular tools would catch. The challenge is that molecular diagnostics require laboratory infrastructure and cold chains that many endemic regions lack, creating a gap between what surveillance ideally needs and what it can realistically deliver.